All
- All
- Articles
- Calendar
- Compliance
- Newsletter
- Position Statements
- Press Release
- Regulatory
- Uncategorized
When Anti-Homeopathy Skeptics Strike
By Deborah Kelly and Alissa Gould, PR Managers, Boiron USA September 1, 2017 It’s typical for skeptics to fire away at anyone who posts or...
The Road to OTC Monograph Reform
By Barbara A. Kochanowski, senior vice president of regulatory and scientific affairs Consumer Healthcare Products Association August 1, 2017 For the past three years, the...
Changes are Coming to Product Labels
By Alvin J. Lorman, AAHP counsel August 1, 2017 Changes are coming to your products’ labels. Not only are there changes to the Homeopathic Pharmacopeia...
FDA’s Division of Nonprescription Drug Products
By Mark Land, AAHP president August 1, 2017 The development and regulation of over-the-counter (OTC) drug products is the responsibility of the Division of Nonprescription...
OTC Monograph Reform
By Mark Land, AAHP president August 1, 2017 Self-medication is an important way in which American consumers treat many types of illnesses. Over-the-counter (OTC) drugs...
AAHP Highlights Expanded Homeopathic Drug Manufacturing Best Practices
MILWAUKIE, Ore. (July 20, 2017) – The American Association of Homeopathic Pharmacists (AAHP) recently hosted a webinar on 2017 improvements to the Homeopathic Pharmacopeia of...
Congress Aiming to Consider User Fee Legislation in July
By Pete Evich, AAHP government relations July 1, 2017 Bills (S 934, HR 2430) that would renew the Food and Drug Administration’s (FDA) ability to...
